Regulus Therapeutics Inc. (RGLS) earnings
RGLS earnings moved a median of -0.68% by the close. Quarterly and annual RGLS reports and results, each read against the price at its own news timestamp. Back to the RGLS overview →
13 measured RGLS earnings events.
Where these RGLS earnings landedvs 13 measured RGLS earnings reactions
| Middle 50% of RGLS earnings reactions | -5.13% to +0.51% |
|---|---|
| Median reaction (to close) | -0.68% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 RGLS earnings events with a measured close landed between -5.13% and +0.51%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Regulus Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +1.15% | +0.51% | |
| Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates | Press release | +1.15% | +0.51% | |
| Form 10-K/A Regulus Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.13% | +0.26% | |
| Form 10-K Regulus Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.73% | +8.03% | |
| Form 10-Q Regulus Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.41% | -0.68% | |
| Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates | Press release | +0.41% | -0.68% | |
| Form 10-Q Regulus Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -5.77% | -5.13% | |
| Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates | Press release | -5.77% | -5.13% | |
| Form 10-Q Regulus Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +6.57% | +3.76% | |
| Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates | Press release | +6.57% | +3.76% | |
| Form 10-K Regulus Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.11% | |
| Form 10-Q Regulus Therapeutics For: Sep 30 | SEC filing · Form 10-Q | — | -5.71% | |
| Regulus Therapeutics Reports Third Quarter 2023 Financial Results and Recent Updates | Press release | — | -5.71% |
Keep exploring
More RGLS: analyst actions → · SEC filings → · RGLS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Immuron Limited - American Depositary Shares (IMRN) | 202 | -0.21% | 29% |
| InfuSystems Holdings, Inc. (INFU) | 202 | 0.00% | 50% |
| Daxor Corporation - Closed End Fund (DXR) | 200 | 0.00% | 50% |
| The Joint Corp. (JYNT) | 200 | 0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.